Effect of Methyldopa in Carcinoid Disease

This publication has 11 references indexed in Scilit:

• THE EFFECT OF A SEROTONIN ANTAGONIST (UML 491) IN CARCINOID DISEASE
  The Lancet, 1961
• A case of carcinoid syndrome, with an account of the use of alpha-methyl-dopa.
  1961
• Über die therapentische Verwendung von α-Methyl-DOPA beim Careinoidsyndrom
  Klinische Wochenschrift, 1961
• Use of Alpha-Methyl-Dopa (Alpha-Methyl-3,4-Dihydroxy-DL-Phenylalanine) in the Management of the Carcinoid Syndrome
  New England Journal of Medicine, 1961
• METABOLIC STUDIES IN CARCINOID SYNDROME - OBSERVATIONS ON USE OF ALPHA-METHYL DOPA, ISONICOTINIC ACID HYDRAZIDE AND SELECTIVE TRYPTOPHAN DEFICIENCY
  1961
• Serotonin Synthesis in Carcinoid Patients
  New England Journal of Medicine, 1960
• Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanine
  Science, 1960
• The effect of intraluminal application of 5‐hydroxytryptamine and 5‐hydroxytryptophan on peristalsis; the local production of 5‐HT and its release in relation to intraluminal pressure and propulsive activity
  The Journal of Physiology, 1958
• PAPER CHROMATOGRAPHY OF URINARY INDOLES
  The Lancet, 1955
• Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanine
  Archives of Biochemistry and Biophysics, 1954